SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to the final regulations implementing those provisions of HR4896 "National Defense Authorization Act for FY2008" related to TRICARE retail pharmacy sales.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD M HODGE | — |
| PATRICK MAYES MCLAIN New | — |
Copyright/Patent/Trademark CPT
All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009" and HR1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009"; and issues related to a regulatory pathway and reimbursement for follow-on biologics
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| EDDIE D EVANS | — |
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN New | — |
Taxation/Internal Revenue Code TAX
Extension of the U.S. R&D tax credit including all such provisions in HR 422 "To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit" and S1203 "Grow Research Opportunities with Tax Credits' Help Act" or "GROWTH Act" ; international tax treaties and the ratification of the Second Protocol to the Income Tax Treaty between the U.S. and France.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GREISSING | — |
| PATRICK MAYES MCLAIN New | — |
| ANN TAYLOR | — |
Health Issues HCR
Provisions and issues related to coverage and payment pharmaceuticals, provisions related to intellectual property and issues related to a regulatory pathway and reimbursement for follow-on biologics, issues related to the importation of prescription drugs, issues related to cancer awareness and access to treatment, issues related to the coordination of care, and issues related to the 340B federal Safety Net Drug Pricing Program including such provisions included or under consideration in draft health care reform legislation "America's Healthy Future Act," and in HR3200 "America's Affordable Health Choices Act," and S1679 "Affordable Health Choices Act"; General issues related to the Medicare Part D program and issues related to awareness of atrial fibrillation and access to treatment.; All provisions of HR2502 "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes"; All provisions of H. Res. 231 "Supporting the goals and ideals of 'Deep Vein Thrombosis Awareness Month'"
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| MARK COIN | — |
| EDDIE D EVANS | — |
| EDWARD GREISSING | — |
| RICHARD M HODGE | — |
| PATRICK MAYES MCLAIN New | — |
| SAIRA SULTAN | — |
| ANN TAYLOR | — |
Medicare/Medicaid MMM
Issues related to reimbursement under Medicare Part B and issues related to hospital acquired conditions and reporting measures to Medicare Part A
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| PATRICK MAYES MCLAIN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.